This in line with another recent large cohort study where PD, in contrast to ALS patients, appeared to have lower levels of circulating immune biomarkers (i.e., leukocytes and haptoglobin) 10–20 years prior to diagnosis, as compared to controls [17]. This evidence concerns the gene HP and Parkinson disease.